Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 21, 2015

View Archived Issues

Inotek Pharmaceuticals begin dosing in pivotal phase III study of trabodenoson

OMT and Armo BioSciences enter into anti-PD-1 antibody agreement

Kolltan Pharmaceuticals reports efficacy data from phase Ib KTN-3379 trial

New phase IIa study investigates simeprevir, odalasvir and AL-335 treatment regimen in HCV

First clinical results presented for novel radiotracer [123/131I]IMAZA

[111In]CP04 could represent a step forward in medullary thyroid carcinoma imaging

Arisaph starts phase II trial of niacin analogue ARI-3037-MO in patients with NAFLD or NASH

HKU and international research teams identify novel PARP-1 complex

DSMB recommends continuation of phase III study of Vyxeos for AML

Luc Therapeutics licenses NMDA modulators for depression to Novartis

Fecal microbiome transplant shows favorable safety profile in HIV-infected subjects

FDA grants orphan drug designation to receptor-Fc fusion protein for the treatment of ovarian cancer

Responses seen with avelumab in trials in mesothelioma, gastric/gastroesophageal junction cancer

Novel NNT gene mutation linked to left ventricular noncompaction

First-in-human results reveal activity of SYD-985 in patients with solid tumors

Curis expands cancer drug pipeline

FDA grants orphan drug designation and fast track status to resunab for cystic fibrosis

FDA approves Coagadex for hereditary factor X deficiency

Tris Pharma's Dyanavel XR approved in U.S. for ADHD in children

Synta terminates phase III trial of ganetespib in NSCLC

InterMune discloses antifibrotic pyridinones

Taisho Pharmaceutical patents orexin receptor antagonists

Sumitomo Dainippon Pharma describes alpha7 nAChR positive allosteric modulators

Eicosis develops soluble epoxide hydrolase inhibitors

Medshine Discovery reports hedgehog signaling pathway inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...